Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...
Holdings announced that its supplemental new drug application, sNDA, of Gvoke VialDx has received U.S Food and Drug ...
Sunshine Biopharma (SBFM) announced that its wholly owned Canadian subsidiary, Nora Pharma, has acquired the rights to two gastrointestinal ...
Both Prucalopride and the second drug Sunshine Biopharma is planning to launch by year end are in the chronic idiopathic constipation submarket of the total gastrointestinal market currently recording ...
Valeant is in talks to sell its Salix drug business, and is considering ... which specialises in gastrointestinal treatments, for around $10 billion. Takeda has been eyeing an acquisition for ...
This and the forthcoming drug are part of Sunshine Biopharma’s strategy to penetrate the chronic idiopathic constipation market, which is part of the larger gastrointestinal market with annual ...
Medical Device Network on MSN10d
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini BThe US Food and Drug Administration (FDA) has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, ...
Both Prucalopride and the second drug Sunshine Biopharma is planning to launch by year end are in the chronic idiopathic constipation submarket of the total gastrointestinal market currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback